CNS Oncology
Volume 11, 2022 - Issue 3
Case Report
Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecan
Nelson S Moss1 Department of Neurological Surgery & Brain Metastasis Center, Memorial Sloan Kettering Cancer Center,New York, NY10065, USACorrespondence[email protected]
https://orcid.org/0000-0002-0930-1681View further author information
https://orcid.org/0000-0002-0930-1681View further author information, Umberto Tosi1 Department of Neurological Surgery & Brain Metastasis Center, Memorial Sloan Kettering Cancer Center,New York, NY10065, USA;2 Department of Neurological Surgery, Weill Cornell Medicine,New York, NY10065, USAhttps://orcid.org/0000-0003-0847-2400View further author information
https://orcid.org/0000-0003-0847-2400View further author information, Bianca D Santomasso3 Department of Neurology, Memorial Sloan Kettering Cancer Center,New York, NY10065, USAhttps://orcid.org/0000-0001-9423-4059View further author information
https://orcid.org/0000-0001-9423-4059View further author information, Kathryn Beal4 Department of Radiation Oncology & Brain Metastasis Center, Memorial Sloan Kettering Cancer Center,New York, NY10065, USAhttps://orcid.org/0000-0003-0989-6723View further author information
https://orcid.org/0000-0003-0989-6723View further author information & Shanu Modi5 Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center,New York, NY10065, USAhttps://orcid.org/0000-0001-6427-7373View further author information
https://orcid.org/0000-0001-6427-7373View further author information